Home » Newsletters » BioWorld

BioWorld

June 23, 1993

View Archived Issues

REPLIGEN BEGINS TWO TRIALS ON RPF4

ISIS PATENT FOR SYNTHESIS METHODS

THE SEVEN STAGES OF AN IDEA

TWO CANDIDATES REMAIN FOR NIH CHIEF

APPOINTMENTS AND ADVANCEMENTS

MATRITECH PLANS TRIALS OF BLADDER CANCER TEST

GENPHARM INKS DEAL WITH EISAI

DNAP GETS ALLOWANCE FOR TOMATO PATENT

SCHERING CONTINUES COLLABORATION WITH CEPHALON

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...